Insider Holders & Insider Ownership - Outlook Therapeutics Inc. (OTLK)

List of insiders holdings for Outlook Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Pillai Arun Kumar
Director
10% Owner
2022-02-01 17:09:010
25,482,529
25,482,529Form 4
BioLexis Pte Ltd.
10% Owner
2024-01-31 16:01:4416,637,024
0
16,637,024Form 13D
Sukhtian Ghiath M.
GMS Ventures & Investments
Director
10% Owner
2024-03-20 17:24:269,266,645
0
9,266,645Form 13D
Mohan Pankaj
Director
10% Owner
2019-01-17 16:45:427,064,553
619,114
7,683,667Form 4
Syntone Ventures LLC
10% Owner
2024-04-17 21:38:262,776,867
0
2,776,867Form 13D
Dagnon Terry
Chief Operations Officer
2023-04-21 21:05:47653,058
0
653,058Form 4
Bahrt Kenneth
Chief Medical Officer
2019-02-19 20:23:56600,000
0
600,000Form 4
TRENARY C RUSSELL III
CEO AND PRESIDENT
2024-03-22 17:00:28455,000
0
455,000Form 4
MCANDREW STEPHEN J
SVP Bus. Strat. & Dev.
2018-10-24 17:02:13200,000
0
200,000Form 4
Griffith Donald J.
Director
2016-11-28 21:59:48144,926
0
144,926Form 4
Windisch Joerg
Director
2018-11-13 16:57:57130,465
0
130,465Form 4
Gangloff Scott A.
SVP, Development & Mfrg
2016-12-22 18:01:49118,573
0
118,573Form 4
THURMAN RANDY H
Director
2024-03-08 16:04:3194,441
0
94,441Form 4
Haller Julia A
Director
2024-03-08 16:30:5094,441
0
94,441Form 4
Huang Andong
Director
2024-03-08 16:18:3994,441
0
94,441Form 4
Auffarth Gerd
Director
2024-03-08 16:14:4894,441
0
94,441Form 4
Gangolli Julian S
Director
2024-03-08 16:13:0094,441
0
94,441Form 4
Sukhtian Faisal Ghiath
Director
2024-03-08 16:08:4394,441
0
94,441Form 4
HILZINGER KURT J
Director
2024-03-08 16:06:5994,441
0
94,441Form 4
Bao Kogan
VP, Analytical Sciences
2016-12-22 18:00:0071,739
0
71,739Form 4
Yamashita Elizabeth A.
VP, Regulatory Affairs
2017-12-26 17:07:2664,648
0
64,648Form 4
Thomas Joe
Director
2019-10-07 18:10:5363,207
0
63,207Form 4
Evanson Jeff
CHIEF COMMERCIAL OFFICER
2024-03-22 17:00:2425,000
0
25,000Form 4
Albrecht Claudio
Director
2017-11-02 18:13:5225,000
0
25,000Form 4
Canute Scott A
Director
2017-10-30 18:02:5315,000
0
15,000Form 4
Dyrness Albert D.
Director
2017-10-30 18:01:5215,000
0
15,000Form 4
Brady Todd C
Director
2017-10-30 18:03:5215,000
0
15,000Form 4
KENYON LAWRENCE A
CHIEF FINANCIAL OFFICER
2024-03-22 17:00:2212,500
0
12,500Form 4
Smith Hoke Robin
Director
2016-11-30 17:27:285138
0
5138Form 4
Haddadin Yezan Munther
Director
2024-03-29 10:39:095048.71
0
5048.71Form 4